Specialist
Former head at Amazon
Agenda
- Amazon’s (NASDAQ: AMZN) expansion efforts into healthcare, highlighting the Haven dissolution and historical challenges of entering healthcare for big tech behemoths
- Business analysis of Amazon Care, including existing synergies to help penetrate the healthcare market
- Inorganic growth opportunities and potential bolt-on adjacencies to improve healthcare portfolio
- Competitive dynamics vs legacy telehealth incumbents such as Teladoc Health (NYSE: TDOC) and American Well (NYSE: AMWL)
- Strategic outlook and execution prospects on building end-to-end healthcare offering
Questions
1.
What are the most important trends and developments you’ve been following in the telemedicine industry over the past 12 months?
2.
How has Amazon Care’s story evolved over the past few years given the dynamics you mentioned?
3.
What major factors led to the dissolution of Haven, Amazon’s healthcare JV with JPMorgan and Berkshire Hathaway? What are the major challenges in entering the healthcare industry for outsiders, even for well funded behemoths such as Amazon?
4.
How would you break down the volume profile for Amazon Care? What is its approximate split across low acuity, urgent care services, preventative care services and chronic care?
5.
How is Amazon Care differentiated from other telehealth providers in markets where it doesn’t have a mobile nurse service? Is its employee engagement or take-up rate higher than other telemedicine providers?
6.
Is there evidence that Amazon Care is more cost-effective and higher-quality than existing telehealth and primary care models? To what extent is Amazon diverting volume from retail clinics, urgent care centres or emergency departments?
7.
What’s important for us to understand about Amazon’s partnership with Crossover Health? How does this fit into the greater Amazon Care business model and strategy?
8.
The Amazon-Crossover Health JV expanded their clinic presence in five major US geographies as of mid 2021. Which areas are the most attractive to enter next? What are the main considerations when opening a care clinic, beyond proximity to Amazon employees?
9.
How does Amazon Diagnostics fit into the Amazon Care platform? What’s the strategic vision there?
10.
How are Alexa and Echo devices being implemented to conduct healthcare visits or facilitate remote patient monitoring? What efficiency or innovation potential is there here?
11.
Is there any credible research suggesting that electronically delivered health nudges are ineffective or even detrimental to consumer health outcomes?
12.
Are you excited about any other tech or innovative capabilities being deployed in Amazon Care?
13.
What are your thoughts on Neil Lindsay’s appointment to oversee Amazon’s healthcare expansion efforts? How might this leadership change affect the company’s strategic direction?
14.
How do you assess the market opportunity with Amazon’s employer customers? Do you think USD 850bn could be a realistic TAM, and what percentage might be penetrable for Amazon as it rolls out Amazon Care to employers?
15.
Where might Amazon target for inorganic growth next to augment its healthcare capabilities? You mentioned distribution names such as Owens & Minor. Which companies in distribution or otherwise might make strategic sense to bolster the company’s offerings?
16.
How would you position Amazon Care against legacy telemedicine incumbents such as Teladoc Health and American Well? How defensible are incumbents’ market positions against encroachment from Amazon, perhaps juxtaposing Amazon’s first-mover advantage and scale vs legacy players’ existing capabilities and pure healthcare focus?
17.
Is there anything else you’d like to highlight around Amazon Care?
Gain access to Premium Content
Submit your details to access up to 5 Forum Transcripts or to request a complimentary one week trial.
The information, material and content contained in this transcript (“Content”) is for information purposes only and does not constitute advice of any type or a trade recommendation and should not form the basis of any investment decision.This transcript has been edited by Third Bridge for ease of reading. Third Bridge Group Limited and its affiliates (together “Third Bridge”) make no representation and accept no liability for the Contentor for any errors, omissions or inaccuracies in respect of it. The views of the specialist expressed in the Content are those of the specialist and they are not endorsed by, nor do they represent the opinion of, Third Bridge. Third Bridge reserves all copyright, intellectual and other property rights in the Content. Any modification, reformatting, copying, displaying, distributing, transmitting, publishing, licensing, creating derivative works from, transferring or selling any Content is strictly prohibited